Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Generex Biotechnology Corp (GNBTQ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 07/31

(Values in U.S. thousands)

	10-2018	07-2018	04-2018	01-2018	10-2017
Cash Flows From Operating Activities
Net Income	17,786	35,949	21,129	17,697	27,527
Depreciation Amortization	26	24	18	2	1
Accounts receivable	1	-34	N/A	0	0
Other Working Capital	1,274	762	531	4	44
Other Operating Activity	-19,443	-38,994	-23,350	-18,776	-28,298
Operating Cash Flow	$-357	$-2,293	$-1,672	$-1,073	$-726

Cash Flows From Investing Activities
PPE Investments	-6	-9	-9	-5	N/A
Other Investing Activity	1,053	0	0	0	0
Investing Cash Flow	$1,046	$-9	$-9	$-5	$N/A

Cash Flows From Financing Activities
Debt Issued	535	126	146	126	172
Other Financing Activity	91	328	213	125	0
Financing Cash Flow	$626	$454	$359	$252	$172

Exchange Rate Effect	2	15	10	-4	12
Beginning Cash Position	1,046	2,879	2,879	2,879	2,879
End Cash Position	2,364	1,046	1,567	2,048	2,337
Net Cash Flow	$1,317	$-1,833	$-1,312	$-831	$-543

Free Cash Flow
Operating Cash Flow	-357	-2,293	-1,672	-1,073	-726
Capital Expenditure	-6	-9	-9	-5	N/A
Free Cash Flow	-363	-2,302	-1,681	-1,079	-726